{
"NDC": {
"NDCCode": "70069-848-30",
"PackageDescription": "30 TABLET, FILM COATED in 1 BOTTLE (70069-848-30) ",
"NDC11Code": "70069-0848-30",
"ProductNDC": "70069-848",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Rilpivirine",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Rilpivirine",
"DosageFormName": "TABLET, FILM COATED",
"RouteName": "ORAL",
"StartMarketingDate": "20260130",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA218798",
"LabelerName": "Somerset Therapeutics, LLC",
"SubstanceName": "RILPIVIRINE HYDROCHLORIDE",
"StrengthNumber": "25",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-02-10",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260130",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}